Meeting
2024 ASCO Gastrointestinal Cancers Symposium
Genomic profile and clinical feature of esophageal squamous cell carcinoma, focusing on MSI, TMB, and HRD status: Analysis with the national database of Japan.
Authors
Ryuichi Morita
Gastoenterology and Hepatology, Kyoto Prefectural University of Medicine, Kyoto, Japan
Ryuichi Morita , Takeshi Ishikawa , Toshifumi Doi , Junichiro Itani , Daiki Sone , Masahiro Iwasaku , Hirotaka Konishi , Atsushi Shiozaki , Hitoshi Fujiwara , Hideyuki Konishi , Koichi Takayama , Yoshito Itoh
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session A: Cancers of the Esophagus and Stomach and Other Gastrointestinal Cancers
Track
Esophageal and Gastric Cancer,Other GI Cancer
Sub Track
Other
Citation
J Clin Oncol 42, 2024 (suppl 3; abstr 412)
DOI
10.1200/JCO.2024.42.3_suppl.412
Abstract #
412
Poster Bd #
K17
Abstract Disclosures
Similar Posters
Poster
2021 ASCO Annual Meeting
Association of ATM mutations in metastatic prostate cancer with differential genomic alteration profiles from homologous recombination deficient and proficient tumors.
First Author: Charles J. Ryan
Poster
2020 ASCO Virtual Scientific Program
Genomics and translational precision oncology for 803 patients with biliary tract cancer.
First Author: Jianzhen Lin
Poster
2023 ASCO Genitourinary Cancers Symposium
Clinical and molecular features of ATM and BRCA2 mutations in metastatic prostate cancer.
First Author: Xiaolei Shi
Poster
2023 ASCO Genitourinary Cancers Symposium
Association of biomarkers and outcomes in patients (pts) with metastatic urothelial carcinoma (mUC) treated with immune checkpoint inhibitors (ICIs).
First Author: Kevin R Reyes